Showing results (61-70 of 223) with videos related to

Sort By:
Pageof 23
The Journal of Clinical Psychiatry|February 4, 2003
Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1)Luca Santarelli, Gabriella Gobbi, Pierre Blier, et al.
Journal of Affective Disorders|May 17, 2011
Strategies to achieve clinical effectiveness: refining existing therapies and pursuing emerging targetsSidney H Kennedy, Allan H Young, Pierre Blier
Journal of Affective Disorders|December 1, 2011
The temporal electrocortical profile of emotive facial processing in depressed males and females and healthy controlsNatalia Jaworska, Pierre Blier, Wendy Fusee, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 20, 2012
Scalp- and sLORETA-derived loudness dependence of auditory evoked potentials (LDAEPs) in unmedicated depressed males and females and healthy controlsNatalia Jaworska, Pierre Blier, Wendy Fusee, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 17, 2014
Acute effects of brexpiprazole on serotonin, dopamine, and norepinephrine systems: an in vivo electrophysiologic characterizationChris A Oosterhof, Mostafa El Mansari, Pierre Blier
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 7, 2015
Asenapine alters the activity of monoaminergic systems following its subacute and long-term administration: an in vivo electrophysiological characterizationChris A Oosterhof, Mostafa El Mansari, Pierre Blier
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 2009
Electrophysiological characterization of the effects of asenapine at 5-HT(1A), 5-HT(2A), alpha(2)-adrenergic and D(2) receptors in the rat brainRamez Ghanbari, Mostafa El Mansari, Mohammed Shahid, et al.
Human Psychopharmacology|October 31, 2002
Enhancement of serotoninergic function - a sometimes insufficient cause of antidepressant actionPierre Blier, Nasser Haddjeri, Steven T Szabo, et al.
The Journal of Clinical Psychiatry|August 28, 2025
Levomilnacipran, but Not Duloxetine, Inhibits Serotonin and Norepinephrine Reuptake Throughout Its Therapeutic RangeKaterina Nikolitch, Jennifer L Phillips, Stephen Daniels, et al.
Pageof 23